Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
AcelRx Pharmaceuticals to Present at 2018 RBC Capital Markets Global Healthcare Conference | ||
By: PR Newswire Association LLC. - 16 Feb 2018 | Back to overview list |
|
REDWOOD CITY, Calif., Feb. 16, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, today announced that Vincent J. Angotti, Chief Executive Officer, will be presenting at the 2018 RBC Capital Markets Global Healthcare Conference. Details of the event are as follows: 2018 RBC Capital Markets Global Healthcare Conference Presentations will be webcast live and can be accessed through the Investors page at www.acelrx.com. For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.acelrx.com. About AcelRx Pharmaceuticals, Inc. For additional information about AcelRx's clinical programs, please visit www.acelrx.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-to-present-at-2018-rbc-capital-markets-global-healthcare-conference-300599982.html SOURCE AcelRx Pharmaceuticals, Inc. |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |